Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-06

Clinical Trial Update: Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer

View source ↗

Summary

A study evaluating a cell-free DNA chromatin immunoprecipitation method to diagnose cancer, with pancreatic cancer as the condition, is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Central Florida | Conditions: Cancer of Pancreas | Status: RECRUITING